Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:329-337, doi:10.1016/j.jacc.2006.08.057 (Published online 3 January 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sauer, A. J.
Right arrow Articles by Zhang, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sauer, A. J.
Right arrow Articles by Zhang, L.

Long QT Syndrome in Adults

Andrew J. Sauer, BS*, Arthur J. Moss, MD*,*, Scott McNitt, MS*, Derick R. Peterson, PhD{dagger}, Wojciech Zareba, MD, PhD*, Jennifer L. Robinson, MS*, Ming Qi, PhD{ddagger}, Ilan Goldenberg, MD*, Jenny B. Hobbs, BA*, Michael J. Ackerman, MD, PhD§, Jesaia Benhorin, MD||, W. Jackson Hall, PhD{dagger}, Elizabeth S. Kaufman, MD, Emanuela H. Locati, MD, PhD#, Carlo Napolitano, MD**, Silvia G. Priori, MD, PhD**, Peter J. Schwartz, MD{dagger}{dagger}, Jeffrey A. Towbin, MD{ddagger}{ddagger}, G. Michael Vincent, MD§§ and Li Zhang, MD§§

* Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, New York
{dagger} Department of Biostatistics, University of Rochester Medical Center, Rochester, New York
{ddagger} Department of Pathology, University of Rochester Medical Center, Rochester, New York
§ Departments of Medicine, Pediatrics, and Molecular Pharmacology, Mayo Clinic College of Medicine, Rochester, Minnesota
|| Department of Cardiology, Bikur Cholim Hospital, Jerusalem, Israel
The Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio
# Section of Cardiology, Department of Clinical and Experimental Medicine, Universita Degli Studi Di Perugia, Perugia, Italy
** Molecular Cardiology, Fondazione S. Maugeri-University of Pavia, Pavia, Italy
{dagger}{dagger} Department of Cardiology, Policlinico S. Matteo IRCCS and University of Pavia, Pavia, Italy
{ddagger}{ddagger} Department of Pediatric Cardiology, Baylor College of Medicine, Houston, Texas
§§ Department of Medicine, University of Utah Medical School, Salt Lake City, Utah.


Figure 1
Figure 1
View larger version (45K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Probability of Any Cardiac Event

Kaplan-Meier estimate of the cumulative probability of any cardiac event (syncope/aborted cardiac arrest [ACA]/long QT syndrome [LQTS]-related sudden death) after age 18 years among mutation-carrying subjects on the basis of: (A) corrected QT interval; (B) number of cardiac events before age 18 years; (C) gender; and (D) genotype. The p value was computed with the log-rank test, and they are unadjusted for covariates. The numbers of subjects remaining at risk are given at 5-year intervals beginning at age 25 years, with the numbers in parentheses indicating the cumulative probability of a cardiac event at the specified age.

 

Figure 2
Figure 2
View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Probability of ACA or LQTS-Related Death

Kaplan-Meier estimate of the cumulative probability of aborted cardiac arrest (ACA) or long QT syndrome (LQTS)-related sudden death (syncope excluded) after age 18 years among mutation-carrying subjects on the basis of: (A) corrected QT interval; (B) number of cardiac events before age 18 years; (C) gender; and (D) genotype. The p value was computed with the log-rank test and is unadjusted for covariates. The numbers of subjects remaining at risk are given at 5-year intervals beginning at age 25 years, with the numbers in parentheses indicating the cumulative probability of a cardiac event at the specified age.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement